BHBryan T. Hackfort

Bryan T. Hackfort

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Bryan T. Hackfort has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Attenuation of Cardiac Dysfunction in the Collagen-Induced Arthritis Mouse Model Mediated by a Reactive Aldehyde Species Inhibitor

    by Wenxian Zhou, Hannah J. Johnson, Michael J. Duryee, Ali Namvaran, Aradhana Thapa, Cole Blasing, Amy Nelson, Engle E. Sharp, Carlos D. Hunter, Bryan Hackfort, et al.

    Individuals with rheumatoid arthritis (RA) experience increased risk of heart failure. Malondialdehyde–acetaldehyde (MAA) adducts are overexpressed and co-localize with citrullinated (CIT) proteins in RA myocardium. This study investigated whether reactive aldehyde species (RASP) inhibitors prevent MAA formation in vitro and attenuate cardiac dysfunction in a collagen-induced arthritis (CIA) mouse model. Among eight RASP inhibitors screened, ADX-246 demonstrated the greatest inhibition of MAA formation in vitro. Mice with early CIA (week 5) exhibited elevated levels of myocardial MAA adducts, myocardial inflammation, and reduced ejection fraction, but normal cardiac collagen deposition and diastolic function vs. control. By weeks 10–12, mice with chronic CIA demonstrated increased levels of myocardial MAA and CIT adducts, perivascular collagen deposition, and diastolic dysfunction. ADX-246 treatment reduced myocardial levels of MAA and CIT adducts, inflammation, fibrosis, and cardiac dysfunction in CIA. While ADX-246 reduced weight loss and attenuated arthritis severity, it did not reduce serum autoantibody levels or serum markers of inflammation or fibrosis. Indices of diastolic dysfunction significantly correlated with myocardial MAA and CIT levels, collagen deposition, arthritis severity, and weight loss. These findings support the hypothesis that targeting myocardial RASP and MAA formation may represent a novel therapeutic approach for preventing cardiac dysfunction in RA.

  • Open Access

    Myocardial Oxygen Saturation Measured by Photoacoustic EKV Imaging

    by Bryan T. Hackfort, Upendra Chalise, Michael J. Daseke, Merry L. Lindsey

    Cardiac remodeling following myocardial infarction (MI) leads to structural and vascular changes in the myocardium. To better understand the mechanisms involved, we used photoacoustic ECG‐gated Kilohertz Visualization imaging (PA EKV) to measure oxygen saturation in the myocardium. Photoacoustic imaging is a noninvasive imaging technique that uses near‐infrared laser light to optically excite molecules in vivo . Oxygenated hemoglobin absorbs laser light at a different wavelength (850nm) from non‐oxygenated hemoglobin (750nm) which allows for the detection of the relative oxygen saturation (sO 2 ) of a tissue and the amount of hemoglobin present (HbT). In this study, photoacoustic imaging was combined with EKV imaging for continuous measurement of sO 2 and HbT throughout the contraction cycle. Imaging was done on C57Bl/6J mice (F, 4–5 months of age) to measure baseline sO 2 levels in the anterior and posterior myocardium. An MI was induced by ligation of the left anterior descending coronary artery. Mice were imaged at days 1, 7, and 14 after MI to measure changes in myocardial sO 2 . All data presented here are from diastole of the long axis orientation and similar results were obtained from short axis measurements. Oxygen saturation on the anterior myocardial wall decreased from 74.7% pre‐MI to 19.9% 1 day after MI (p<0.0001). Oxygen saturation showed recovery at 7 (54.9%, p=0.023) and 14 (49.9%, p=0.007) days post infarct, yet remained significantly reduced from pre‐MI levels. Oxygen saturation was lower on the posterior myocardium (57.2%) compared to the anterior myocardium but did not change following MI. Our results demonstrate oxygen saturation begins to recover 7 days after MI as the heart adapts to ligation and neoangiogenesis is stimulated. This study validates the use of PA EKV for the measurement of oxygen saturation in the infarcted myocardium. Support or Funding Information: We acknowledge funding from National Institutes of Health under Award Numbers HL075360, HL129823, and HL137319, and from the Biomedical Laboratory Research and Development Service of the Veterans Affairs Office of Research and Development under Award Numbers 5I01BX000505. The UNMC Ultrasound Core is supported by an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institution of Health under grant P30 GM127200.


  • Open Access

    Exercise Training Promotes Cardiac Hydrogen Sulfide Biosynthesis and Mitigates Pyroptosis to Prevent High-Fat Diet-Induced Diabetic Cardiomyopathy

    by Sumit Kar, Hamid R. Shahshahan, Bryan T. Hackfort, Santosh K. Yadav, Roopali Yadav, Tyler N. Kambis, David J. Lefer, Paras K. Mishra

    Obesity increases the risk of developing diabetes and subsequently, diabetic cardiomyopathy (DMCM). Reduced cardioprotective antioxidant hydrogen sulfide (H2S) and increased inflammatory cell death via pyroptosis contribute to adverse cardiac remodeling and DMCM. Although exercise training (EX) has cardioprotective effects, it is unclear whether EX mitigates obesity-induced DMCM by increasing H₂S biosynthesis and mitigating pyroptosis in the heart. C57BL6 mice were fed a high-fat diet (HFD) while undergoing treadmill EX for 20 weeks. HFD mice developed obesity, hyperglycemia, and insulin resistance, which were reduced by EX. Left ventricle pressure-volume measurement revealed that obese mice developed reduced diastolic function with preserved ejection fraction, which was improved by EX. Cardiac dysfunction was accompanied by increased cardiac pyroptosis signaling, structural remodeling, and metabolic remodeling, indicated by accumulation of lipid droplets in the heart. Notably, EX increased cardiac H₂S concentration and expression of H₂S biosynthesis enzymes. HFD-induced obesity led to features of type 2 diabetes (T2DM), and subsequently DMCM. EX during the HFD regimen prevented the development of DMCM, possibly by promoting H₂S-mediated cardioprotection and alleviating pyroptosis. This is the first report of EX modulating H₂S and pyroptotic signaling in the heart.